Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells

Cancer Research

Volumn 63, Issue 2, 2003, Pages 277-281

  Pouliot, Frédéric ^a   Blais, Alexandre ^a   Labrie, Claude ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BONE MORPHOGENETIC PROTEIN 2 RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR; GREEN FLUORESCENT PROTEIN; SMAD PROTEIN; SMAD1 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE G1 PHASE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION;

BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; BONE MORPHOGENETIC PROTEINS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; DNA-BINDING PROTEINS; GROWTH INHIBITORS; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SMAD PROTEINS; SMAD1 PROTEIN; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0037439923     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Miyazono, K., Kusanagi, K., and Inoue, H. Divergence and convergence of TGF-β/BMP signaling. J. Cell Physiol., 187: 265-276, 2001.
2. Groeneveld, E. H., and Burger, E. H. Bone morphogenetic proteins in human bone regeneration. Eur. J. Endocrinol., 142: 9-21, 2000.
3. Kleeff, J., Maruyama, H., Ishiwata, T., Sawhney, H., Friess, H., Buchler, M. W., and Korc, M. Bone morphogenetic protein-2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology, 116: 1202-1216, 1999.
4. Ide, H., Yoshida, T., Matsumoto, N., Aoki, K., Osada, Y., Sugimura, T., and Terada, M. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res., 57: 5022-5027, 1997.
5. Chen, S., Guttridge, D. C., Tang, E., Shi, S., Guan, K., and Wang, C. Y. Suppression of tumor necrosis factor-mediated apoptosis by nuclear factor κB-independent bone morphogenetic protein/Smad signaling. J. Biol. Chem., 276: 39259-39263, 2001.
6. Izumi, M., Fujio, Y., Kunisada, K., Negoro, S., Tone, E., Funamoto, M., Osugi, T., Oshima, Y., Nakaoka, Y., Kishimoto, T., Yamauchi-Takihara, K., and Hirota, H. Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway. J. Biol. Chem., 276: 31133-31141, 2001.
7. Hjertner, O., Hjorth-Hansen, H., Borset, M., Seidel, C., Waage, A., and Sundan, A. Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood, 97: 516-522, 2001.
8. Franzen, A., and Heldin, N. E. BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1). Biochem. Biophys. Res. Commun., 285: 773-781, 2001.
9. Kawamura, C., Kizaki, M., Yamato, K., Uchida, H., Fukuchi, Y., Hattori, Y., Koseki, T., Nishihara, T., and Ikeda, Y. Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood, 96: 2005-2011, 2000.
10. Clement, J. H., Sanger, J., and Hoffken, K. Expression of bone morphogenetic protein-6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor. Int. J. Cancer, 80: 250-256, 1999.
11. Arnold, S. F., Tims, E., and McGrath, B. E. Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2. Cytokine, 11: 1031-1037, 1999.
12. Pouliot, F., and Labrie, C. Role of Smad1 and Smad4 proteins in the induction of p21WAF1. Cip1 during bone morphogenetic protein-induced growth arrest in human breast cancer cells. J. Endocrinol., 172: 187-198, 2002.
13. Ghosh-Choudhury, N., Ghosh-Choudhury, G., Celeste, A., Ghosh, P. M., Moyer, M., Abboud, S. L., and Kreisberg, J. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Biochim. Biophys. Acta, 1497: 186-196, 2000.
14. Ghosh-Choudhury, N., Woodruff, K., Qi, W., Celeste, A., Abboud, S. L., and Ghosh-Choudhury, G. Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation. Biochem. Biophys. Res. Commun., 272: 705-711, 2000.
15. Pouliot, F., and Labrie, C. Expression profile of agonistic Smads in human breast cancer cells: absence of regulation by estrogens. Int. J. Cancer. 81: 98-103, 1999.
16. Fiszer-Szafarz, B., Szafarz, D., and Guevara de Murillo, A. A general, fast, and sensitive micromethod for DNA determination application to rat and mouse liver, rat hepatoma, human leukocytes, chicken fibroblasts, and yeast cells. Anal. Biochem., 110: 165-170, 1981.
17. Frisch, A., and Wright, C. V. XBMPRII, a novel Xenopus type II receptor mediating BMP signaling in embryonic tissues. Development (Camb.), 125: 431-442, 1998.
18. Ishikawa, T., Yoshioka, H., Ohuchi, H., Noji, S., and Nohno, T. Truncated type II receptor for BMP-4 induces secondary axial structures in Xenopus embryos. Biochem. Biophys. Res. Commun., 216: 26-33, 1995.
19. Enomoto-Iwamoto, M., Iwamoto, M., Mukudai, Y., Kawakami, Y., Nohno, T., Higuchi, Y., Takemoto, S., Ohuchi, H., Noji, S., and Kurisu, K. Bone morphogenetic protein signaling is required for maintenance of differentiated phenotype, control of proliferation, and hypertrophy in chondrocytes. J. Cell Biol., 140: 409-418, 1998.
20. Kawakami, Y., Ishikawa, T., Shimabara, M., Tanda, N., Enomoto-Iwamoto, M., Iwamoto, M., Kuwana, T., Ueki, A., Noji, S., and Nohno, T. BMP signaling during bone pattern determination in the developing limb. Development (Camb.), 122: 3557-3566, 1996.
21. Sakou, T. Bone morphogenetic proteins: from basic studies to clinical approaches. Bone, 22: 591-603, 1998.
22. Kimura, N., Matsuo, R., Shibuya, H., Nakashima, K., and Taga, T. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J. Biol. Chem., 275: 17647-17652, 2000.
23. Lai, C. F., and Cheng, S. L. Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-β in normal human osteoblastic cells. J. Biol. Chem., 277: 15514-15522, 2002.
24. Nohe, A., Hassel, S., Ehrlich, M., Neubauer, F., Sebald, W., Henis, Y. I., and Knaus, P. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J. Biol. Chem., 277: 5330-5338, 2002.
25. Rudarakanchana, N., Flanagan, J. A., Chen, H., Upton, P. D., Machado, R., Patel, D., Trembath, R. C., and Morrell, N. W. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum. Mol. Genet., 11: 1517-1525, 2002.